1. Home
  2. ABP vs NCPL Comparison

ABP vs NCPL Comparison

Compare ABP & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • NCPL
  • Stock Information
  • Founded
  • ABP 2004
  • NCPL 1984
  • Country
  • ABP United States
  • NCPL United States
  • Employees
  • ABP N/A
  • NCPL N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • ABP Health Care
  • NCPL Finance
  • Exchange
  • ABP Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • ABP 12.3M
  • NCPL 11.7M
  • IPO Year
  • ABP N/A
  • NCPL N/A
  • Fundamental
  • Price
  • ABP $0.32
  • NCPL $3.19
  • Analyst Decision
  • ABP Strong Buy
  • NCPL
  • Analyst Count
  • ABP 1
  • NCPL 0
  • Target Price
  • ABP $4.00
  • NCPL N/A
  • AVG Volume (30 Days)
  • ABP 15.4M
  • NCPL 906.1K
  • Earning Date
  • ABP 08-18-2025
  • NCPL 09-15-2025
  • Dividend Yield
  • ABP N/A
  • NCPL N/A
  • EPS Growth
  • ABP N/A
  • NCPL N/A
  • EPS
  • ABP N/A
  • NCPL N/A
  • Revenue
  • ABP $183,000.00
  • NCPL $812,612.00
  • Revenue This Year
  • ABP N/A
  • NCPL N/A
  • Revenue Next Year
  • ABP N/A
  • NCPL $101.16
  • P/E Ratio
  • ABP N/A
  • NCPL N/A
  • Revenue Growth
  • ABP 88.66
  • NCPL N/A
  • 52 Week Low
  • ABP $0.15
  • NCPL $1.41
  • 52 Week High
  • ABP $11.19
  • NCPL $8.75
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • NCPL 40.41
  • Support Level
  • ABP N/A
  • NCPL $2.92
  • Resistance Level
  • ABP N/A
  • NCPL $3.43
  • Average True Range (ATR)
  • ABP 0.00
  • NCPL 0.84
  • MACD
  • ABP 0.00
  • NCPL -0.38
  • Stochastic Oscillator
  • ABP 0.00
  • NCPL 7.47

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: